Cooperative Agreement NU51IP000920

Award Date 9/30/21
Completion Date 9/29/26
Dollars Obligated $275K
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.318
Assistance Type
Cooperative Agreement
Place of Performance
Vietnam
Similar Awards
This Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $7,577,508.00 in funding to the Vietnam Administration of Disease Prevention (VAAC) to foster a sustainable national HIV response and end AIDS as a public health threat in Vietnam by 2030 under the President's Emergency Plan for AIDS Relief (PEPFAR). The award supports technical assistance, service delivery, and capacity-building activities...
This Cooperative Agreement award, valued at $234,158, was provided by the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The purpose of this agreement is to conduct national surveillance and response activities for foreign animal diseases in poultry, specifically highly pathogenic avian influenza (HPAI) and virulent Newcastle disease (VND). The key activities to be...
This Cooperative Agreement award from the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA APHIS), under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025), provides $205,344.00 to the Indiana State Poultry Association Inc. to conduct national surveillance and response activities for avian health. The key products and services to be delivered under this award include: conducting active and passive surveillance...
The U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) awarded a $234,158 cooperative agreement to the Texas Poultry Improvement Association under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025). The purpose of this 1-year agreement, effective April 1, 2024, is to conduct national surveillance and response activities for foreign animal diseases in poultry, specifically highly pathogenic avian influenza (HPAI) and virulent...
The National Science Foundation's Biological Sciences (CFDA 47.074) Federal Grant Program has awarded a $1,487,500 Cooperative Agreement to the University of California, Davis to establish the Center for Insights into the Pre-Emergence Phase of Pandemics (CI3P). This multi-year project aims to develop innovative scientific and technological solutions to detect signals of pathogens circulating in natural reservoirs and provide insights into how pandemic threats emerge. The key objectives include:...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $6,000,000 Cooperative Agreement to the National Health Laboratory Service (NHLS) in South Africa under CFDA Program 93.318, "Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security." The 5-year award, effective September 1, 2024, supports NHLS's collaborative research on influenza and other respiratory pathogens in South Africa. Key activities include...
This Cooperative Agreement award from the United States Department of Agriculture's Animal and Plant Health Inspection Service (USDA APHIS) under the Plant and Animal Disease, Pest Control, and Animal Care program (CFDA 10.025) provides $149,801.00 to the Connecticut Department of Agriculture's Bureau of Agricultural Development and Research Preservation Division to conduct avian influenza surveillance activities. The key activities to be performed include: (A) conducting avian influenza testing...
The University of Missouri System, under a $650,000 project grant from the USDA National Institute of Food and Agriculture (NIFA) Agriculture and Food Research Initiative (AFRI) program, is developing safe and effective live attenuated swine influenza vaccines using Newcastle disease virus (NDV) as the vector. The project aims to address the challenges with current swine influenza vaccines, which often fail to provide cross-protection against diverse virus strains. The key products and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $7,994,888 Cooperative Agreement under the Allergy and Infectious Diseases Research (CFDA 93.855) program to Research Triangle Institute (RTI International) to establish and maintain the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (REVAMPP) Coordinating and Data Sharing Center (CDSC). The CDSC will coordinate the REVAMPP network, comprised of 6-8 research centers, to...
This cooperative agreement award from the U.S. Department of Agriculture Animal and Plant Health Inspection Service provides $346,677 to the Nebraska Department of Agriculture to support livestock disease surveillance, monitoring, and emergency response planning activities through March 31, 2024. Under the award, the state will conduct routine testing of poultry, cattle, swine, sheep, cervids, goats, and equine for disease surveillance purposes. It will also fund foreign animal and zoonotic...

SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN VIETNAM - THE NATIONAL INFLUENZA SURVEILLANCE SYSTEM (NISS) IN VIETNAM WAS ESTABLISHED IN 2006 UNDER COOPERATIVE AGREEMENT WITH US CDC, AND GRADUALLY BECAME NATIONAL ROUTINE INFLUENZA SURVEILLANCE SYSTEM IN THE COUNTRY. THE COMPONENTS PROPOSED AND APPLIED FOR THIS FUNDING OPPORTUNITY ARE DESIGNED TO MAINTAIN AND IMPROVE THE CURRENT EXISTING NISS FOR BOTH EPIDEMIOLOGICAL SURVEILLANCE AND LABORATORY CAPACITY. IF AWARDED, THE PURPOSES OF THE COOPERATIVE AGREEMENT ARE TO IMPROVE QUALITY OF THE EXISTING INFLUENZA SURVEILLANCE AND ENHANCE ANIMAL-HUMAN HEALTH SECTOR COLLABORATION IN SURVEILLANCE AND RESPONSE TO AVIAN AND PANDEMIC INFLUENZA IN VIETNAM. THE PROJECT CONSISTS OF TWO COMPONENTS, THE FIRST COMPONENT COVERS INFLUENZA CORE ACTIVITIES DESIGNED TO MAINTAIN AND ENHANCE THE QUALITY OF EXISTING NISS AND THE SECOND COMPONENT CONTAINS ACTIVITIES TO ENHANCE CAPACITY OF THE NISS FOR NON INFLUENZA PATHOGEN SURVEILLANCE. THE FIRST INTENT IS TO IMPROVE CAPACITY OF THE ROUTINE SURVEILLANCE TO MONITOR INFLUENZA ACTIVITY AND TO DETECT AND RESPOND TO ANY SIGNAL OF A PANDEMIC INFLUENZA. THE SECOND INTENT IS TO STRENGTHEN HUMAN-ANIMAL COLLABORATION IN AVIAN INFLUENZA SURVEILLANCE TO DETECT ANIMAL INFLUENZA HUMAN INFECTIONS FOR EARLY RESPONSE. THE THIRD INTENT IS TO SUPPORT NISS TO FULLY PARTICIPATE IN THE WHO GLOBAL INFLUENZA SURVEILLANCE AND RESPONSE SYSTEM (GISRS) THROUGH REGULAR INFLUENZA INFORMATION REPORTING, AND TO PROMOTE THE NATIONAL INFLUENZA CENTERS (NIC) TO MAINTAIN CAPACITY TO SHARE INFLUENZA POSITIVE SAMPLES TO WHO-CC ON REGULAR BASIS. THE SECOND COMPONENT IS DESIGNED TO EXTEND CAPACITY TO DETECT AND MONITOR NON INFLUENZA PATHOGENS THAT PRESENT A POTENTIAL RISK FOR OUTBREAK IN HUMAN, ESPECIALLY HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUSES.

Posted 8/6/21